India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
14
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.1%
1 terminated/withdrawn out of 14 trials
91.7%
+5.2% vs industry average
21%
3 trials in Phase 3/4
9%
1 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Secular Trends in the Prevalence of Cardiometabolic Risk Factors Among Teenage School Children in Urban South India
Role: lead
The Severity of COVID 19 in Diabetes and Non-diabetes Patients
Role: lead
Study of Association of Salivary Adipokines With Prediabetes and Type 2 Diabetes Mellitus
Role: lead
A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients
Role: lead
Secular Trends in the Prevalence of Diabetes in India
Role: lead
Development and Testing of a New Generation of Diabetic Footwear
Role: collaborator
Effectiveness of Automated Mobile Phone Based Text Messaging on the Improvement of Glycaemic Outcomes
Role: lead
A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
Role: lead
Post Trial Analysis of a Primary Prevention Study in Asian Indians
Role: lead
Use of Mobile Technology to Promote Sustained Lifestyle Changes to Prevent Type 2 Diabetes in India and the UK
Role: lead
Sitagliptin in Prevention of Type 2 Diabetes Mellitus
Role: lead
Use of Information Technology in the Prevention of Diabetes
Role: lead
"Information Technology Methodology for Patient Motivation in Diabetes Management."
Role: lead
Role of Pioglitazone in Preventing Diabetes
Role: collaborator
All 14 trials loaded